Amphetamine-like analogues as a short term adjunct in management of exogenous obesity have several absolute contraindications like history of cardiovascular disease and hyperthyroidism, but not diabetes. A case study in Case Reports in Endocrinology describes a patient with a history of type 1 diabetes who experienced diabetic ketoacidosis (DKA) after starting diethylpropion HCI for weight loss.